The alpha-1 acid glycoprotein (orosomucoid; AAG) is a normal constituent of human plasma (650±215 µg ml−1) which increases in concentration as much as fivefold in association with acute inflammation and cancer, and thus is recognised as an acute phase protein1,2. AAG consists of a single polypeptide chain, has a molecular weight of 44,100, and contains ∼45% carbohydrate including 12% sialic acid; it is the most negatively charged of the plasma proteins3. Certain of the biological properties of AAG are related to its sialic acid content1,3; thus, clearance and immunogenicity of AAG are markedly increased on desialisation4,5. The biological functions of AAG are largely unknown. AAG has the ability to inhibit certain lymphocyte reactivities including blastogenesis in response to concanavalin A, phytohaemagglutinin and allogeneic cells6, and these inhibitory effects are enhanced in association with desialisation7. In view of these observations, a report that unphysiologically large (5–15 mg ml−1) amounts of AAG inhibit the platelet aggregation induced by ADP and adrenaline8, and evidence that a sialic acid-deficient species of AAG appears elevated in several chronic disease states9,10, we compared the effects of AAG and its desialised counterpart (AAG-D) on platelet aggregation. We report that desialisation of AAG is associated with increased expression of activity inhibitory to the platelet aggregation otherwise observed on stimulation with ADP, collagen or thrombin.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Jeanloz, R. W. in Glycoproteins (ed. Gottschalk, A.) 565–611 (Elsevier, New York, 1966).
Winzler, R. in Glycoproteins of Blood Cells and Plasma (eds Jamieson, G. A. & Greenwald, T. J.) 204–218 (Lippincott, New York, 1971).
Schmid, K. in The Plasma Proteins: Structure, Function and Genetic Control (ed. Putnam, F. W.) 163–228 (Academic, New York, 1975).
Morell, A., Gregoriadis, S., Scheinberg, H., Hickman, J. & Ashwell, G. J. biol Chem. 246, 1461–1467 (1971).
Athineos, E., Thornton, M. & Winzler, R. J. Proc. Soc. exp. Biol. Med. 111, 354–256 (1963).
Chiu, K. M., Mortensen, R. F., Osmand, A. P. & Gewurz, H. Immunology 32, 997–1005 (1977).
Costello, M., Baum, L., Hansen, B. & Gewurz, H. Fedn Proc. 38, 1365 (1979).
Snyder, S. & Coodley, E. L. Archs intern. Med. 136, 778–781 (1976).
Schmid, K., Burke, J. F., Debray-Sachs, M. & Tokiten, K. Nature 204, 75–77 (1964).
Rudman, D., Treadwell, P., Volger, W. R., Howard, C. H. & Hollin, B. Cancer Res. 52, 1951–1957 (1972).
Schmid, K. J. Am. chem. Soc. 75, 60–68 (1953).
Warren, L. J. biol. Chem. 234, 1971–1975 (1959).
Ferguson, K. A. Metabolism 13, 985–1002 (1964).
Fiedel, B. A. & Gewurz, H. J. Immun. 117, 1073–1078 (1976).
Fiedel, B. A. & Gewurz, H. J. Immun. 116, 1289–1294 (1976).
Whitehead, P. H. & Winzler, R. J. Archs Biochem. Biophys. 126, 657–663 (1968).
About this article
Cite this article
Costello, M., Fiedel, B. & Gewurz, H. Inhibition of platelet aggregation by native and desialised alpha-1 acid glycoprotein. Nature 281, 677–678 (1979). https://doi.org/10.1038/281677a0
This article is cited by
Archives of Gynecology and Obstetrics (2012)
Investigation of serum concentrations and immunohistochemical localization of α1-acid glycoprotein in tumor dogs
Veterinary Research Communications (2011)
Sialic acid residues play a pivotal role in α1-acid glycoprotein (AGP)-induced generation of reactive oxygen species in chemotactic peptide pre-activated neutrophil granulocytes
Inflammation Research (2010)
International Urology and Nephrology (1997)
Glycosylation ofα 1 glycoprotein in septic shock: Changes in degree of branching and in expression of sialyl Lewisx groups
Glycoconjugate Journal (1996)